Cellapeutics bio logo

Cellapeutics bio

Global standard of cell reprogramming platform

8 employees · est. 2020 · Korea South

VS
Coeptis Therapeutics logo

Coeptis Therapeutics

A biopharmaceutical company developing innovative cell therapy platforms for patients with cancer (NASDAQ: COEP)

7 employees · est. 1996

Coeptis Therapeutics is the older company (2020 vs 1996).

Side-by-Side Comparison

Cellapeutics bio Coeptis Therapeutics
Founded
2020 1996 older
Headquarters
Korea South Not tracked yet
Employees
8 7
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care, Pharmaceutical
Funding Stage
Seed Post Ipo Equity
Total Funding
Not tracked yet $15.32M
Funding Rounds
3 4
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Cell Biology, Neuroscience, Drug Development, Cell Therapy, Somatic Cell Reprogramming, Regenerative Medicine Biopharmaceutical, Cell Therapy, Cancer Treatment, Pharmaceutical Development, Innovation, Partnerships, Product Pipeline, Acquisition, Pharmaceutical Company, Oncology, NASDAQ, Therapy Platforms, Drug Development, Clinical Trials
Website
cellapeuticsbio.com coeptistx.com
Cellapeutics bio logo

About Cellapeutics bio

Cellapeutics Bio, with the slogan "Global standard of cell reprogramming platform," is a bio-venture company founded in 2020. The company operates in the Biotechnology and Pharmaceutical industries, with its headquarters located in Korea South. Cellapeutics Bio specializes in developing cell therapy...

Coeptis Therapeutics logo

About Coeptis Therapeutics

Coeptis Therapeutics (NASDAQ: COEP) is a biopharmaceutical company founded in 1996, dedicated to developing innovative cell therapy platforms for patients battling cancer. Specializing in the Biotechnology, Health Care, and Pharmaceutical industries, Coeptis Therapeutics has recently secured a signi...

We will tell you when either one moves

BounceWatch watches Cellapeutics bio and Coeptis Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cellapeutics bio and Coeptis Therapeutics — by email.

Frequently Asked Questions

Cellapeutics bio — Global standard of cell reprogramming platform. Coeptis Therapeutics — A biopharmaceutical company developing innovative cell therapy platforms for patients with cancer (NASDAQ: COEP). Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cellapeutics bio has raised undisclosed funding while Coeptis Therapeutics has raised $15.32M.
Cellapeutics bio and Coeptis Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cellapeutics bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cellapeutics bio on 12 Sep 2024, and Coeptis Therapeutics on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy